tiprankstipranks
Trending News
More News >
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market

Marvel Biosciences Corp (MRVL) Financial Statements

Compare
39 Followers

Marvel Biosciences Corp Financial Overview

Marvel Biosciences Corp's market cap is currently C$7.83M. The company's EPS TTM is C$; its P/E ratio is -3.00; Marvel Biosciences Corp is scheduled to report earnings on December 18, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -547.37KC$ 0.00C$ -887.52KC$ -1.38MC$ -613.10K
Operating IncomeC$ -1.25MC$ -1.22KC$ -2.32MC$ -2.54MC$ 806.33K
EBITDAC$ -1.94MC$ -1.54MC$ -2.25MC$ -2.55MC$ -1.25M
Net IncomeC$ -2.21MC$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04M
Balance Sheet
Cash & Short-Term InvestmentsC$ 128.85KC$ 345.77KC$ 556.62KC$ 593.21KC$ 2.39M
Total AssetsC$ 326.71KC$ 491.31KC$ 672.39KC$ 913.54KC$ 2.47M
Total DebtC$ 2.31MC$ 1.71MC$ 1.00MC$ 0.00C$ 0.00
Net DebtC$ 2.18MC$ 1.36MC$ 443.38KC$ -593.21KC$ -2.39M
Total LiabilitiesC$ 4.33MC$ 3.32MC$ 2.39MC$ 718.00KC$ 112.48K
Stockholders' EquityC$ -4.01MC$ -2.83MC$ -1.72MC$ 195.54KC$ 2.36M
Cash Flow
Free Cash FlowC$ -1.15MC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37M
Operating Cash FlowC$ -1.15MC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 381.57K
Financing Cash FlowC$ 933.41KC$ 968.64KC$ 1.30MC$ 394.00KC$ 3.16M
Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History

Marvel Biosciences Corp Debt to Assets

Marvel Biosciences Corp Cash Flow

Marvel Biosciences Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.